Tenderwize
Back to tender search

Parenteral Nutrition Combination Solutions

GWQ ServicePlus AG·Düsseldorf, Germany·Deadline May 10, 2027 · 257 days left·Open·Supplies
Sign up to saveOpen documents
Original notice title

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V zu Lösungen zur parenteralen Ernährung Kombinationen (ATC-Code: B05BA10).

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Postal submission only is indicated, so late or incomplete physical delivery could invalidate participation.

The notice states the buyer believes the arrangement falls outside cartel procurement law due to no selection decision...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Non-exclusive rebate agreements for pharmaceutical products under § 130a(8) SGB V.
  • Product scope: solutions for parenteral nutrition combinations (ATC code B05BA10).
Show full summary

This is a German supplies notice for non-exclusive pharmaceutical rebate agreements under § 130a(8) SGB V for parenteral nutrition combinations (ATC B05BA10). The procedure is open, with postal submission only, and the contract is intended to start on 01.09.2025. The notice indicates an access model where interested companies may join on the same terms during the contract term. No contract value is stated. Procurement documents are available on the buyer portal, but only the TED XML notice text was provided for analysis.

Risks

Postal submission only is indicated, so late or incomplete physical delivery could invalidate participation.

The notice states the buyer believes the arrangement falls outside cartel procurement law due to no selection decision...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Signed contract in duplicate is required.
  • Proof of pharmaceutical marketing authorization via extract from the public AMIce database is required.

Administrative

  • Submission is postal only; electronic submission is not allowed.

Buyer

Location

Düsseldorf, DEU

Buyer profile

Open profile

Identifier

DE258895210

Activity

Health

Lots (1)

LOT-0000

Parenteral Nutrition Combination Solutions

Non-exclusive rebate agreement for parenteral nutrition combination products (ATC B05BA10). The lot text indicates an accession model open to all interested companies on equal terms during the contract term, with contract documents and related information available via the buyer portal. This lot information comes from the structured notice and XML notice text.

SuppliesEU fundedElectronic submission

Location

DEA11, Germany

Duration

Aug 2025 - Jun 2027

Category

Pharmaceutical products

Deadline

Deadline May 10, 2027

Procurement Details

Publication date
06 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
519396-2025

Documents (1)

Procurement document 1

Similar tenders

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3